Compounded Semaglutide: Prescription Rules and Telehealth

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide reaches patients only through a specific chain of requirements: a licensed 503A pharmacy, a valid prescription, and a prescriber who has actually evaluated the patient. Those requirements — not the molecule itself — are what separate a legitimate compounded preparation from a risky one. This guide from the PlexusDx Education Hub focuses on the prescription and oversight side of compounded semaglutide, then covers the regulatory backdrop and safety checks.

What a 503A pharmacy is allowed to compound

503A pharmacies are state-licensed compounders that prepare patient-specific prescriptions on a valid prescriber's order. Federal law lets them compound in three broad situations: when a product isn't commercially available, when it appears on the FDA drug shortage list, and when a patient-specific formulation — a distinct strength, combination, or vehicle — is medically necessary for an individual. Oversight is shared between state boards of pharmacy and the FDA.

Why a valid prescription and clinical evaluation come first

Compounded semaglutide is a prescription preparation, which means it can only be dispensed after a qualified prescriber evaluates the patient and issues a patient-specific order. That evaluation — whether conducted in person or through a telehealth visit — is where contraindications should be reviewed and the appropriate formulation determined. A pharmacy dispensing without that step is a warning sign, not a shortcut.

What the 2024–2025 shortage resolutions changed

The FDA declared semaglutide and tirzepatide in shortage in 2022, and during those declarations 503A pharmacies could compound the molecules under the shortage-list pathway. The agency resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing — but not closing — the legitimate compounding window. Compounded semaglutide remains available through the not-commercially-available and patient-specific pathways where clinically justified.

Compounded semaglutide versus the brand molecule

Although the active ingredient is the same molecule, a compounded preparation is legally and factually different from an FDA-approved brand product. It doesn't pass through the same FDA manufacturing review, relies on the pharmacy's own quality processes, and may use different vehicles, strengths, or combinations. Quality varies by pharmacy, and "compounded" is not a regulatory synonym for "generic."

Formulation variations you may encounter

Semaglutide paired with cyanocobalamin (vitamin B12) is a common combination; the B12 can reduce injection-site irritation for some patients and may support those who are B12-deficient. "Microdose" formulations deliver lower amounts than standard titration schedules, sometimes for patients who react strongly to label-directed doses. All such strength combinations are patient-specific per the prescriber order. PlexusDx offers a Microdose GLP-1 Protocol within its Weight Management Protocols.

Screening for a legitimate provider and pharmacy

Confirm state licensure for the pharmacy and verify that the prescribing provider genuinely evaluates you and reviews contraindications. Treat vendors that ship without a prescription, take only cryptocurrency, or advertise "research chemical" products as red flags. Properly compounded products should include patient-specific labeling, lot numbers, beyond-use dates, and storage instructions consistent with USP <797> (nonsterile) or USP <797>/<800> (sterile) standards.

Starting upstream with your biology

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, but the decision starts before the pharmacy. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including trait-level variants such as FTO and MC4R, and TCF7L2 that shape baseline appetite and energy-balance biology. It does not predict response to compounded semaglutide or any specific formulation — it supplies the context behind every GLP-1 protocol.

Why the prescription chain protects you

It is tempting to view the prescription and evaluation requirements as red tape, but they are the main safeguards standing between a patient and an unsafe product. A prescriber who evaluates you can catch contraindications, and a state-licensed pharmacy operating under that order is accountable to regulators in a way an anonymous online seller is not. When a source removes those steps, it removes the protections along with them. Treating the requirements as features rather than obstacles is the single most useful mindset when weighing any compounded semaglutide option with a qualified clinician.

To start with that context, take the Precision Peptide Genetic Test, or explore the Weight Management Protocols directly.

Frequently Asked Questions About Compounded Semaglutide

Do I need a prescription for compounded semaglutide?

Yes. A licensed 503A pharmacy can only compound and dispense semaglutide under a valid, patient-specific prescriber order following a clinical evaluation. That evaluation may occur in person or via telehealth. Any source offering compounded semaglutide without a prescription should be treated as illegitimate and unsafe.

Is compounded semaglutide the same as the brand?

No. Compounded semaglutide doesn't undergo the FDA manufacturing review brand products do and may differ in strength, vehicle, combinations, and quality controls. It is not a generic, and quality varies by pharmacy. PlexusDx Weight Management Protocols work with licensed compounding pathways and publish per-protocol pricing.

Why is B12 added to some compounded semaglutide?

Cyanocobalamin (vitamin B12) is sometimes included because it can reduce injection-site discomfort for some patients and may support those who are B12-deficient. It is a patient-specific formulation choice made by the prescribing provider, not a standard component of every compounded semaglutide preparation.

How does the Precision Peptide Genetic Test fit in?

It does not predict response to compounded semaglutide or any specific formulation. It analyzes pathway-level variants such as FTO and MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology — upstream context that informs a GLP-1 protocol conversation rather than a drug-response prediction.

Find more compounding and coverage guidance across the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.